1. Delta‐like 3 localizes to neuroendocrine cells and plays a pivotal role in gastrointestinal neuroendocrine malignancy
    Kentaro Matsuo et al, 2019, Cancer Science CrossRef
  2. Elevated DLL3 in stomach cancer by tumor-associated macrophages enhances cancer-cell proliferation and cytokine secretion of macrophages
    Jian-Bin Ye et al, 2022, Gastroenterology Report CrossRef
  3. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition
    Xiaojie Ding et al, 2019, Life Sciences CrossRef
  4. Necrobiology of Liver Cancer: Apoptosis and Related Forms of Cell Death
    Arthur Zimmermann, 2017, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
  5. DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis
    Humaira Noor et al, 2022, Genomics CrossRef
  6. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression
    Xin Wang et al, 2016, Oncotarget CrossRef
  7. Differential expression of the Notch1 receptor, and its ligands Dll1, Dll3 and Dll4 in distinct human pituitary adenoma subtypes
    Jianfu Zhang et al, 2017, Oncology Letters CrossRef
  8. Methylation‑associated inactivation of JPH3 and its effect on prognosis and cell biological function in HCC
    Yi Huang et al, 2022, Molecular Medicine Reports CrossRef
  9. Molecular epigenetic targets for liver diseases: current challenges and future prospects
    Robert Zeidler et al, 2017, Drug Discovery Today CrossRef
  10. Oncogenic role of the Notch pathway in primary liver cancer
    JIE LU et al, 2016, Oncology Letters CrossRef
  11. Identification of DLL3-related genes affecting the prognosis of patients with colon adenocarcinoma
    Jinyu Xiang et al, 2023, Frontiers in Genetics CrossRef
  12. Delta‐like canonical Notch ligand 3 as a potential therapeutic target in malignancies: A brief overview
    Kentaro Matsuo et al, 2021, Cancer Science CrossRef
  13. The Role of DLLs in Cancer: A Novel Therapeutic Target


    Meng-Xi Xiu et al, 2020, OncoTargets and Therapy CrossRef
  14. Methylation Patterns and Chromatin Accessibility in Neuroendocrine Lung Cancer
    Elsa Arbajian et al, 2020, Cancers CrossRef
  15. Necrobiology of Liver Cancer: Apoptosis and Related Forms of Cell Death
    Arthur Zimmermann, 2016, Tumors and Tumor-Like Lesions of the Hepatobiliary Tract CrossRef
  16. Upregulated delta-like protein 3 expression is a diagnostic and prognostic marker in endometrial cancer
    Juan Wang et al, 2018, Medicine CrossRef
  17. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism
    Anu Loukola et al, 2015, PLOS Genetics CrossRef
  18. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile
    B.C.M. Hermans et al, 2019, Lung Cancer CrossRef
  19. Delta-like 3 is silenced by HBx via histone acetylation in HBV-associated HCCs
    Hiroki Hamamoto et al, 2018, Scientific Reports CrossRef
  20. A functional and protein-protein interaction analysis of neuroepithelial cell transforming gene 1 in hepatocellular carcinoma
    Ke Ye et al, 2014, Tumor Biology CrossRef
  21. DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail
    Megumi Furuta et al, 2019, Cancer Science CrossRef
  22. Diagnostic and prognostic value of STAP1 and AHNAK methylation in peripheral blood immune cells for HBV-related hepatopathy
    Libo Sun et al, 2023, Frontiers in Immunology CrossRef
  23. The Notch ligand delta-like 3 promotes tumor growth and inhibits Notch signaling in lung cancer cells in mice
    San-Ming Deng et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  24. Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV‐related liver diseases
    Libo Sun et al, 2018, Cancer Medicine CrossRef
  25. Advances in new targets for immunotherapy of small cell lung cancer
    Zitong Zheng et al, 2024, Thoracic Cancer CrossRef